A United States jury on Wednesday ordered Johnson & Johnson to pay $29 million (Rs 202 crore) to a woman diagnosed with cancer, who alleged that the asbestos in the firm's talcum-powder-based products caused her disease, Reuters reported.
The verdict said that the baby powder was a "substantial contributing factor" in her illness.
Her suit is one of many that link cancers to asbestos in Johnson & Johnson's talc-based products and contend that the company concealed the health risk for decades.
Johnson & Johnson is facing some 13,000 similar lawsuits around the country.
The lawsuit was brought by Leavitt was the first of more than a dozen J&J talc cases scheduled for trial in 2019.
Asbestos is a term for a group of minerals often found near talc, which is widely used in cosmetics.
The company has insisted that its talc-based products are demonstrably safe but it has lost a string of court cases. The jury declined to award punitive damages.
"Yet another jury has rejected J&J's misleading claims that its talc was free of asbestos", said Moshe Maimon, a lawyer for Leavitt, in a statement on Wednesday.
Leavitt's trial originally included Johnson & Johnson talc supplier, Imerys Talc America, a unit of Imerys SE, as a co-defendant.
While earlier talc lawsuits alleged talc itself causes ovarian cancer, plaintiffs' lawyers have more recently focused on arguing asbestos contamination in talc caused ovarian cancer and mesothelioma, a form of cancer linked to asbestos exposure.
Two previous cases have led to victories against the conglomerate, including a July 2018 multi-plaintiff ovarian cancer case that awarded $4.69 billion in damages to the victims.
J&J has appealed all of the plaintiff verdicts, and the company said it is confident the verdicts would be overturned on appeal.